Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded trial

(2015) Lone Baandrup et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The Longitudinal Course of Cognitive Impairment in Schizophrenia

(2014) Richard S. E. Keefe   JOURNAL OF CLINICAL PSYCHIATRY

Benzodiazepine use and risk of Alzheimer's disease: case-control study

(2014) S. Billioti de Gage et al.   BMJ-British Medical Journal

Melatonin in Alzheimer’s Disease

(2013) Li Lin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects

(2012) George Anderson et al.   METABOLIC BRAIN DISEASE

Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementia

(2012) C. Bocti et al.   BMJ-British Medical Journal

Benzodiazepine use and risk of dementia: prospective population based study

(2012) S. Billioti de Gage et al.   BMJ-British Medical Journal

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol

(2011) Lone Baandrup et al.   BMC Psychiatry

Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)

(2011) John Gallacher et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic

(2011) Rei Kitajima et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies

(2010) Terry E Goldberg et al.   NEUROPSYCHOPHARMACOLOGY

Neuropsychological Performance in Older Patients With Schizophrenia: A Meta-Analysis of Cross-sectional and Longitudinal Studies

(2010) Farzin Irani et al.   SCHIZOPHRENIA BULLETIN

The Association Between Dementia and Long-Term Use of Benzodiazepine in the Elderly: Nested Case–Control Study Using Claims Data

(2009) Chi-Shin Wu et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Melatonin as a potential therapeutic agent in psychiatric illness

(2009) Maria D. Maldonado et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action

(2009) Venkataramanujan Srinivasan et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Neurocognition in first-episode schizophrenia: A meta-analytic review.

(2009) Raquelle I. Mesholam-Gately et al.   NEUROPSYCHOLOGY

A meta-analytic investigation of neurocognitive deficits in bipolar illness: Profile and effects of clinical state.

(2009) Matthew M. Kurtz et al.   NEUROPSYCHOLOGY

Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation

(2009) Kailash Manda et al.   PROGRESS IN NEUROBIOLOGY

Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)

(2008) R KEEFE et al.   SCHIZOPHRENIA RESEARCH